Launch-Ready Therapeutic Specialty Rep

Inizio Engage; Pflugerville (TX); On-site; USD 125,000 - 150,000; Full time

Benefits offered by this job

Bonus eligibility

Health care benefits

Retirement benefits

Paid holidays

Vacation

Sick days

Job summary

Aquestive Therapeutics is launching a Therapeutic Specialty Representative (TSR) to introduce Anaphylm to healthcare providers—an oral, device-free epinephrine option potentially addressing barriers to emergency treatment.

Ideal candidates bring 3+ years in pharma sales, strong payer navigation skills, and a track record of exceeding targets. Some travel is expected as part of a national launch strategy and field-based education.

Qualifications

• Bachelor's degree required.
• 3+ years of pharmaceutical, specialty, or B2B sales success with proven targets.
• Deep understanding of payer coverage, prior authorization workflows, and access barrier navigation.
• Strong analytical skills with demonstrated ability to translate data into actionable territory strategies.
• Willingness to travel overnight 30% for customer meetings, conferences, and sales meetings.

Responsibilities

• Design and execute territory business plans identifying high-potential accounts and drive market penetration.
• Educate healthcare providers on Anaphylm's value and address unmet patient needs.
• Navigate payer coverage dynamics to overcome prior authorization barriers and enable patient access.
• Maintain CRM with detailed call notes, payer feedback, sampling activity, and next steps.
• Ensure compliance with PDMA sampling, AE reporting, and promotional guidelines.

Skills

Analytical skills

Education

Bachelor's degree

Job description

Aquestive Therapeutics is launching a Therapeutic Specialty Representative (TSR) to introduce Anaphylm to healthcare providers—an oral, device-free epinephrine option potentially addressing barriers to emergency treatment.

Ideal candidates bring 3+ years in pharma sales, strong payer navigation skills, and a track record of exceeding targets. Some travel is expected as part of a national launch strategy and field-based education.